Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic Dermatitis
Clinical trial NCT05432596 · COMPLETED
Trial details
- NCT number
- NCT05432596
- Sponsor
- Aclaris Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-11
- Primary completion
- 2023-10-26
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.